We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
Cap. Flow
-$440M
Cap. Flow %
-4.14%
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$151M
3
BSX icon
Boston Scientific
BSX
+$121M
4
AMZN icon
Amazon
AMZN
+$104M
5
TRU icon
TransUnion
TRU
+$81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.87%
2 Healthcare 20.58%
3 Financials 10.9%
4 Technology 10.13%
5 Industrials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUN icon
651
Cedar Fair
FUN
$1.78B
$2.73M 0.03%
51,956
-54,497
-51% -$2.91M
XLP icon
652
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$2.72M 0.03%
48,536
+28,853
+147% +$1.54M
VCTR icon
653
Victory Capital Holdings
VCTR
$6.08B
$2.72M 0.03%
180,966
-210,307
-54% -$2.56M
MIXT
654
DELISTED
MIX TELEMATICS LIMITED
MIXT
$2.72M 0.03%
162,955
+128,941
+379% +$2.21M
BEDU
655
DELISTED
Bright Scholar Education Holdings
BEDU
$2.71M 0.03%
65,401
+12,723
+24% +$547K
BLK icon
656
Blackrock
BLK
$164B
$2.7M 0.03%
+6,318
New +$2.65M
GRFS
657
Grifois
GRFS
$5.16B
$2.69M 0.03%
133,498
+115,170
+628% +$2.2M
EXPR
658
DELISTED
Express, Inc.
EXPR
$2.66M 0.03%
+31,117
New +$3.14M
CSL icon
659
Carlisle Companies
CSL
$13.6B
$2.66M 0.03%
21,712
-8,832
-29% -$1.02M
SBH icon
660
Sally Beauty Holdings
SBH
$1.4B
$2.65M 0.02%
+143,763
New +$2.57M
CDR
661
DELISTED
Cedar Realty Trust, Inc
CDR
$2.64M 0.02%
117,718
-14,374
-11% -$323K
CNH
662
CNH Industrial
CNH
$13.8B
$2.58M 0.02%
290,904
-645,432
-69% -$5.78M
PBR icon
663
Petrobras
PBR
$121B
$2.57M 0.02%
161,546
-18,357
-10% -$291K
MDGL icon
664
Madrigal Pharmaceuticals
MDGL
$12.6B
$2.56M 0.02%
+20,462
New +$2.54M
RCKT icon
665
Rocket Pharmaceuticals
RCKT
$348M
$2.56M 0.02%
+145,992
New +$2.3M
TCDA
666
DELISTED
Tricida, Inc. Common Stock
TCDA
$2.55M 0.02%
+65,912
New +$1.54M
EGRX
667
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2.53M 0.02%
50,188
-61,276
-55% -$2.73M
BEL
668
DELISTED
Belmond Ltd.
BEL
$2.53M 0.02%
101,570
-5,021
-5% -$125K
OMF icon
669
OneMain Financial
OMF
$6.9B
$2.52M 0.02%
+79,388
New +$2.46M
NI icon
670
NiSource
NI
$22.4B
$2.51M 0.02%
+87,627
New +$2.36M
LLL
671
DELISTED
L3 Technologies, Inc.
LLL
$2.5M 0.02%
12,127
-17,887
-60% -$3.54M
AHCO icon
672
AdaptHealth
AHCO
$1.46B
$2.5M 0.02%
250,000
ALGR
673
DELISTED
Allegro Merger Corp
ALGR
$2.5M 0.02%
250,000
WSC icon
674
WillScot Mobile Mini Holdings
WSC
$4.8B
$2.49M 0.02%
224,611
+40,662
+22% +$422K
SINA
675
DELISTED
Sina Corp
SINA
$2.49M 0.02%
42,015
-22,067
-34% -$1.32M

Similar funds

Marshall Wace's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.

  • Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
  • Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
  • Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
  • Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
  • Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
  • Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
  • Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.